Ignite Creation Date:
2024-05-05 @ 5:08 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00396045
Status:
COMPLETED
Last Update Posted:
2006-11-30
First Post:
2006-11-02
Brief Title:
Melphalan Prednisone and CC-5013 Revlimid as Induction Therapy in Multiple Myeloma
Sponsor:
University of Turin Italy
Organization:
University of Turin Italy
Organization Data
Organization:
University of Turin Italy
Class:
OTHER
Study ID:
RV-MM-PI-026
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Turin Italy
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None